James LeBar, Director at Zomedica Pharmaceuticals Corp. (ZOM), sold 200,000 shares at $2.15 ($430K) on 2018-08-28, disclosed to the SEC on 2018-08-30.
Open-market sale of $430k ZOM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.